SCHEMBL7326447

SCHEMBL7326447

Cc1cccc(C2(OC[C@H](N)C(=O)O)c3ccccc3-c3ccccc32)c1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 12/20 0.47
LMNA P02545 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
SLC1A5 Q15758 2/20 0.39
SLC6A1 P30531 1/20 0.35
S1PR4 O95977 1/20 0.35
S1PR5 Q9H228 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314762 0.88 KIF11 (0.51) KIF11SLC1A5
SCHEMBL7322275 0.87 KIF11 (0.40) KIF11LMNANPSR1SLC1A5SLC6A1
SCHEMBL7320451 0.87 KIF11 (0.40) KIF11LMNANPSR1SLC1A5SLC6A1
SCHEMBL7323248 0.87 KIF11 (0.40) KIF11LMNANPSR1SLC1A5EDNRB
SCHEMBL7323114 0.87 KIF11 (0.55) KIF11CYP1A2CYP2C19HIF1ASLC1A5
SCHEMBL7314907 0.87 KIF11 (0.55) KIF11CYP1A2CYP2C19HIF1ASLC1A5
SCHEMBL7318407 0.86 KIF11 (0.59) KIF11CYP1A2CYP2C19HIF1ASLC1A5
SCHEMBL7309988 0.84 KIF11 (0.46) KIF11CYP1A2CYP2C19HIF1ASLC1A5
SCHEMBL7313597 0.80 KIF11 (0.49) KIF11CYP1A2CYP2C19HIF1ASLC1A5
SCHEMBL7326122 0.79 KIF11 (0.59) KIF11CYP1A2CYP2C19HIF1ASLC1A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999041227-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-08-19 WO claimed
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed